Clinical study to investigate the efficiency of vascular occlusion prevention by ticagrelor after stent implantation in patients with peripheral artery disease (PAD) and high platelet reactivity during treatment with clopidogrel

Trial Profile

Clinical study to investigate the efficiency of vascular occlusion prevention by ticagrelor after stent implantation in patients with peripheral artery disease (PAD) and high platelet reactivity during treatment with clopidogrel

Recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Dec 2014

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Peripheral arterial disorders
  • Focus Therapeutic Use
  • Acronyms PAVK-TAH-Studie
  • Most Recent Events

    • 29 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top